[Retracted] Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI

Table 1

General information comparison (n, %, ± s).

Index	Control group (n = 35)	Observation group (n = 35)	t/χ^2/Z value	P value
Age	56.26 ± 9.76	58.58 ± 10.17	0.974	0.334
Men/women	21/14	20/15	0.059	0.808
BMI (kg/m^2)	25.95 ± 3.64	26.12 ± 3.21	0.207	0.836
Diabetes time (age)	8.37 ± 7.12	9.11 ± 6.07	0.468	0.641
Systolic blood pressure (mmHg)	131.08 ± 17.43	129.05 ± 15.26	0.518	0.606
Diastolic blood pressure (mmHg)	79.93 ± 8.61	80.13 ± 7.12	0.106	0.916
Smoking	8 (22.86)	5 (14.29)	0.850	0.356
Gensini score
≤30 score	7 (20.00)	8 (22.86)	0.085	0.771
>30∼60 score	22 (62.86)	20 (57.14)	0.238	0.626
>60 score	6 (17.14)	7(20.00)	0.095	0.759
History of hypertension	21 (60.00)	20 (57.14)	0.059	0.808
Past history of myocardial infarction	3 (8.57)	4 (11.43)	0.159	0.690
History of atrial fibrillation	2 (5.71)	1 (2.86)	0.348	0.555
History of stroke	2 (5.71)	3 (8.57)	0.215	0.643
History of peripheral arterial disease	1 (2.86)	2 (5.71)	0.348	0.555